US BROKER MOVES: LOW upgraded at Citi; GTM sees multiple downgrades

• Autodesk (ADSK) Upgraded to Buy at BofA; PT USD 300
• Bentley Systems (BSY) Upgraded to Buy at BofA; PT USD 40
• Celanese (CE) Upgraded to Overweight at JPMorgan; PT USD 68
• Lowe's (LOW) Upgraded to Buy at Citi; PT USD 285
• Matador Resources (MTDR) Upgraded to Buy at Truist Secs; PT USD 67
• Seadrill (SDRL) Upgraded to Buy at Fearnley; PT USD 58

• Accuray (ARAY) Downgraded to Hold at Jefferies; PT 35 cents
• Emerald Holding (EEX) Downgraded to Neutral at Rosenblatt Securities Inc
• Gitlab (GTLB) Downgraded to Market Perform at Raymond James
• LENZ Therapeutics Inc (LENZ) Downgraded to Neutral at Piper Sandler; PT USD 12
• Toast (TOST) Downgraded to Neutral at Rothschild & Co Redburn; PT USD 35
• United Parks & Resorts (PRKS) Downgraded to Hold at Stifel; PT USD 40
• ZoomInfo (GTM) Downgraded to Hold at Canaccord; PT USD 5
• ZoomInfo (GTM) Downgraded to Underweight at Piper Sandler; PT USD 4
• ZoomInfo (GTM) Downgraded to Hold at Stifel; PT USD 4

• Aevex (AVEX) Initiated at New Outperform at William Blair
• Aevex (AVEX) Initiated at New Outperform at Raymond James; PT USD 35
• Aevex (AVEX) Initiated at New Buy at Jefferies; PT USD 32
• Aevex (AVEX) Initiated at New Outperform at Baird; PT USD 38
• Aevex (AVEX) Initiated at New Outperform at RBC; PT USD 31
• Aevex (AVEX) Initiated at New Overweight at JPMorgan; PT USD 33
• Aevex (AVEX) Initiated at New Buy at Goldman; PT USD 34
• Alamar Biosciences (ALMR) Initiated at New Outperform at Leerink; PT USD 35
• Alamar Biosciences (ALMR) Initiated at New Buy at TD Cowen; PT USD 30
• Alamar Biosciences (ALMR) Initiated at New Overweight at JPMorgan; PT USD 30
• Alamar Biosciences (ALMR) Initiated at New Buy at Stifel; PT USD 28
• Annexon (ANNX) Initiated at New Neutral at Goldman; PT USD 7
• Chesapeake Utilities (CPK) Reinstated Equal-Weight at Wells Fargo
• Design Therapeutics (DSGN) Initiated at New Overweight at Cantor
• Dexcom (DXCM) Initiated at New Buy at Benchmark
• Enliven Therapeutics (ELVN) Initiated at New Buy at Guggenheim; PT USD 80
• Forum Markets (FRMM) Initiated at New Buy at Clear Street; PT USD 11
• H2O America (HTO) Reinstated Equal-Weight at Wells Fargo; PT USD 60
• Insulet (PODD) Initiated at New Buy at Benchmark
• Kailera Therapeutics (KLRA) Initiated at New Outperform at Evercore ISI
• Kailera Therapeutics (KLRA) Initiated at New Outperform at Leerink; PT USD 36
• Kailera Therapeutics (KLRA) Initiated at New Buy at TD Cowen; PT USD 57
• Kailera Therapeutics (KLRA) Initiated at New Outperform at William Blair
• Kailera Therapeutics (KLRA) Initiated at New Buy at Jefferies; PT USD 48
• Kailera Therapeutics (KLRA) Initiated at New Overweight at JPMorgan; PT USD 30
• Lumentum (LITE) Initiated at New Buy at CTBC Securities; PT USD 1,250
• MaxLinear (MXL) Reinstated Buy at Benchmark; PT USD 28
• MiniMed Group (MMED) Initiated at New Buy at Benchmark
• New Jersey Resources (NJR) Reinstated Overweight at Wells Fargo
• Northwest Natural (NWN) Reinstated Underweight at Wells Fargo; PT USD 50
• ONE Gas (OGS) Reinstated Underweight at Wells Fargo; PT USD 85
• Palvella Therapeutics (PVLA) Initiated at New Overweight at Stephens; PT USD 220
• Southwest Gas (SWX) Reinstated Overweight at Wells Fargo; PT USD 105
• Spire (SR) Reinstated Overweight at Wells Fargo; PT USD 96
• Sunbelt Rentals (SUNB) Initiated at New Outperform at Bernstein; PT USD 86
• Tandem Diabetes (TNDM) Initiated at New Hold at Benchmark
• UGI (UGI) Reinstated Overweight at Wells Fargo; PT USD 46
• Unitil (UTL) Initiated at New Equal-Weight at Wells Fargo; PT USD 56
• Varonis Systems (VRNS) Initiated at New Buy at Rosenblatt Securities Inc
• Versant Media (VSNT) Initiated at New Neutral at JPMorgan; PT USD 43

The recent upgrades and downgrades indicate a mixed sentiment in the market, with Lowe's being notably upgraded to 'Buy' at Citi, suggesting potential upward momentum for its shares. Meanwhile, multiple downgrades for ZoomInfo signal concern over its outlook, which could weigh on its stock performance. Overall, these changes could influence investor sentiment across the retail and tech sectors, impacting trading strategies and portfolio reallocations.